Delirium in oncology;LES SYNDROMES CONFUSIONNELS EN CANCEROLOGIE

Bulletin du Cancer

Volumn 83, Issue 2, 1996, Pages 115-128

  Reich, M G ^a   Razavi, D ^b  

^a CENTRE OSCAR LAMBRET   (France)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

cancer; delirium; organic mental disorder

Indexed keywords

CHLORPROMAZINE; CLORAZEPATE; CLORAZEPATE DIPOTASSIUM; DROPERIDOL; HALOPERIDOL; HYDROXYZINE; LORAZEPAM; MIDAZOLAM; MORPHINE; PROTHIPENDYL; SULTOPRIDE; THIORIDAZINE; ANTINEOPLASTIC AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; HYPNOTIC SEDATIVE AGENT; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT;

CANCER; DELIRIUM; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; METASTASIS; NEOPLASM; PREVALENCE; PSYCHOLOGICAL ASPECT; RISK FACTOR;

ANALGESICS, OPIOID; ANTINEOPLASTIC AGENTS; ANTIPSYCHOTIC AGENTS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM; COGNITION DISORDERS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPNOTICS AND SEDATIVES; NEOPLASMS; PREVALENCE; RISK FACTORS;

EID: 0030052255     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Adams F, Quesada JR, Gutterman JU. Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer. JAMA 1984;252:938-41
2. Adams F, Fernandez F, Andersson BS. Emergency pharmacotherapy of delirium in the critically ill cancer patient. Psychosomatics 1986;27:33-7
3. Adams F. Emergency intravenous sedation of the delirious, medically ill patient. J Clin Psychiatry 1988;49:22-6
4. Aisner J, Ostrow S, Govindan S et al. Leptomeningeal carcinomatosis in small cell carcinoma of the lung. Med Pediatr Oncol 1981;9:47-59
5. American Psychiatric Association. DSM-III. Diagnostic and statistical manual of mental disorders, 3rd ed. Washington DC: American Psychiatric Association, 1980
6. American Psychiatric Association. DSM-III-R. Diagnostic and statistical manual of mental disorders, revised. Washington DC: American Psychiatric Association, 1987
7. American Psychiatric Association. DSM-IV. Diagnostic and statistical manual of mental disorders, 4th ed. Washington DC: American Psychiatric Association, 1994
8. Belgi BI. Mental impairment in unilateral frontal tumours: role of the laterality of the lesion. Int J Neurosci 1987;32: 799-810
9. Benton AL. La signification des tests de rétention visuelle dans le diagnostic clinique. Rev Psychol Appl 1952;2: 151-79
10. Black PMcL. Brain tumors. N Engl J Med 1991;324: 1555-64
11. Bottomlev DM, Hanks GW. Subcutaneous midazolam infusion in palliative care. J Pain Symptom Management 1990; 5:259-61
12. Breitbart W, Holland JC. Psychiatric complications of cancer. In: Brain MC, Carbone PP, eds. Current therapy in hematology-oncology, vol 3. Philadelphia: BC Decker Inc, 1988:268-74
13. Breitbart W. Psycho-oncology: Depression, anxiety, delirium. Semin Oncol 1994;21:754-69
14. Breitbart W. Identifying patients at risk for, and treatment of major psychiatric complications of cancer. Support Care Cancer 1995;3:45-60
15. Bruera E. Severe organic brain syndrome. J Palliat Care 1991;7:36-8
16. Bruera E, Schoeller T, Montejo G. Organic hallucinosis in patients receiving high doses of opiates for cancer pain. Pain 1992;48:397-9
17. Burtis WJ, Brady TG, Orloff JJ et al. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 1990;322:1106-12
18. Capwell RR, Carter R. Organic anxiety syndrome secondary to metastatic brain tumor. Psychosomatics 1991;32: 231-3
19. Daut RL, Cleeland CS. The prevalence and severity of pain in cancer. Cancer 1982;50:1913-8
20. De Angelis LM, Delattre J, Posner JB. Radiation induced dementia in patients cured of brain metastases. Neurology 1989;39:789-96
21. Denicoff KD, Rubinow DR, Papa MZ et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine- activated killer cells. Ann Intern Med 1987;107: 293-300
22. Derogatis LR, Morrow GR, Fetting J et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983;249:751-7
23. Desforges JF. Delirium in the elderly patient. N Engl J Med 1989;320:578-82
24. DiMaggio JR, Brown R, Baile WF et al. Hallucinations and ifosfamide-induced neurotoxicity. Cancer 1994;73:1509-14
25. Eller KC, Sision AC, Breitbart W et al. Morphine-induced acute confusional states: A retrospective analysis [Abstract]. 39th Annual Meeting of the Academy of Psychosomatic Medicine San Diego (CA) November, 1992
26. Fainsinger R, Miller MJ, Bruera E et al. Symptom control during the last week of life in a palliative care unit. J Palliat Care 1991;7:5-11
27. Fainsinger R, Bruera E. Treatment of delirium in a terminally ill patient. J Pain Symptom Management 1992;7:54-6
28. Fleishman SB, Lesko LM. Delirium and dementia. In: Holland JC, Rowland JH, eds. Handbook of psychooncology: psychological care of the patient with cancer. New York: Oxford University Press, 1989:342-55
29. Fleishman SB, Lesko LM, Breitbart W. Treatment of organic mental disorders in cancer patients. In: Breitbart W, Holland JC, eds. Psychiatric aspects of symptom management in cancer patients. Washington: American Psychiatric Press Inc, 1993:23-47
30. Fogel BS, Mills MJ, Landen JE. Legal aspects of the treatment of delirium. Hosp Community Psychiatry 1986;37: 154-8
31. Folstein MF, Folstein SE, McHugh PR. "Mini Mental State": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1979;12:189-98
32. Galasko CSB, Burn JI. Hypercalcemia in patients with advanced mammary cancer. Br Med J 1971;3:573-7
33. Golinger RC. Delirium in the surgical patients. Am Surg 1989;55:549-51
34. Gross AJ, Steinberg SM, Reilly JG et al. Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium. Cancer Res 1993;53:67-74
35. Grossman SA, Moynihan TJ. Neoplastic meningitidis. Neurol Clin 1991;9:843-56
36. Hansen M, Hansen H, Hirsch F et al. Hormonal polypeptides and amine metabolites in small cell carcinoma of the lung, with special reference to stage and subtypes. Cancer 1980;45:1432-7
37. Jacobs JW, Bernhard MR, Delgado A et al. Screening for organic mental syndromes in medically ill. Ann Intern Med 1977;86:40-6
38. Jameson D, Alavi A, Jolles P et al. Positron emission tomography in the investigation of central nervous system disorders. Radiol Clin North Am 1988;26:1075-88
39. Kaplan RS, Wiernik PM. Neurotoxicity of antineoplastic drugs. Semin Oncol 1982;9:103-30
40. Kornblith PL, Walker MD, Cassady JR. Neoplasms of the central nervous system. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer, principles, and practice of oncology, 2nd ed. Philadelphia: JB Lippincott Company, 1985: 1437-1510
41. Levine PM, Silberfarb PM, Lipowski ZJ. Mental disorders in cancer patients: a study of 100 psychiatric referrals. Cancer 1978;42:1385-91
42. Lipowski ZJ. Delirium in the elderly patient. N Engl J Med 1989;320:578-82
43. Lipowski ZJ. Head Injury. Epilepsy and brain tumor. In: Delirium: acute confusional states. New York: Oxford University Press, 1990;17:399-409
44. Lisner M, Feld R, Payne DG et al. Late neurological complications after prophylactic irradiation in patients with small-cell lung cancer: The Toronto Experience. J Clin Oncol 1990;8:215-21
45. Lokich JJ. The frequency and clinical biology of the ectopic hormone syndromes of small cell carcinoma. Cancer 1982; 50:2111-4
46. MacKenzie TB, Popkin MK. Stress response syndrome occuring after delirium. Am J Psychiatry 1980;137:1433-5
47. Massie MJ, Holland J, Glass E. Delirium in terminally ill cancer patients. Am J Psychiatry 1983;140:1048-50
48. Meadows AT, Evans AE. Effects of chemotherapy on the central nervous system. Cancer 1976;37:1079-85
49. Meyers CA, Yung A. Delayed neurotoxicity of intraventricular interleukine-2: a case report. J Neurooncol 1993;15: 265-7
50. Moulaert P. Treatment of acute non specific delirium with IV haloperidol in surgical intensive care patients. Acta Anaesthesiol Belg 1989;40:183-6
51. Mundy GR, Ibbotson KJ, D'Souza SM et al. The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms. N Engl J Med 1984;310:1718-27
52. Patchell RA, Posner JB. Cancer and the nervous system. In: Holland JC, Rowland JH, eds. Handbook of psychooncology: psychological care of the patient with cancer. New York: Oxford University Press, 1989:327-41
53. Peterson LG, Popkjn MK. Neuropsychiatric effects of chemotherapeutic agents for cancer. Psychosomatics 1980;21: 141-53
54. Posner JB. Neurological complications of systemic cancer. Med Clin North Am 1979;63:783-800
55. Posner JB. Non metastatic effects of cancer on the nervous system. In: Wyngaarden JB, Smith LH, eds. Cecil textbook of medecine, 18th edition. Philadelphia: WB Saunders Company, 1988:1104-7
56. Razavi D, Lossignol D, Hanot R et al. Les troubles mentaux organiques. In: Razavi D, Delvaux N, eds. Psycho-oncologie. Paris: Masson, 1994:114-24
57. Richeimer SH. Psychological intervention in delirium. An important component of management. Postgrad Med 1987; 81:173-80
58. Ron MA. Psychiatric manifestations of frontal lobe tumors. Br J Psychiatry 1989;155:735-8
59. Shapiro WR. Intracranial tumors. In: Wyngaarden JB, Smith LH, eds. Cecil textbook of medecine, 18th edition. Philadelphia: WB Saunders Company, 1988:2229-35
60. Sheline GE. Irradiation injury of the human brain: a review of clinical experience. In: Gilbert J, Kagan AR, eds. Radiation damage to the nervous system. New York: Raven Press, 1980:39-58
61. Sorensen SC, Eagan RT, Scott M. Meningeal carcinomatosis in patients with primary breast and lung cancer. Mayo Clin Proc 1984;59:91-4
62. Stiefel FC, Breitbart W, Holland JC. Corticosteroids in cancer: Neuropsychiatric complications. Cancer Invest 1989;7:479-91
63. Taylor SG, Ayer JP, Morris RS. Cortical steroids in treatment of cancer. JAMA 1950;14:1058-64
64. Thomas RI, Cameron DJ, Fahs MC. A prospective study of delirium and prolonged hospital stay: exploratory study. Arch Gen Psychiatry 1988;45:937-40
65. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1988;23:89-97
66. Tune L, Folstein MF. Post-operative delirium. Adv Psychosom Med 1986;15:51-68
67. Uribe VM. Psychiatric symptoms and brain tumor. Am Family Physician 1986;34:95-8
68. Ventafridda V, Ripamonti C, De Conno F et al. Symptom prevalence and control during cancer patients last days of life. J Palliat Care 1990;6:7-11
69. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982; 49:759-72
70. Webb WL, Gehi M. Electrolyte and fluid imbalance: neuropsychiatric manifestations. Psychosomatics 1981;22: 199-203
71. Weinrich S, Sarna L. Delirium in the older person with cancer. Cancer 1994;74:2079-91
72. Yap HY, Yap BS, Tashima CK et al. Meningeal carcinomatosis in breast cancer. Cancer 1978;42:283-6
73. Young DF, Posner JB. Nervous system toxicity of the chemotherapeutic agents. In: Vinken PJ, Bruyn GW, eds. Handbook of chemical Neurology. Neurological manifestations of systemic diseases, part II, vol 39. New York: Elsevier North-Holland, 1980:91-129